About Nexopro
Building clinical and commercial pathways for innovative medical technologies across the GCC since 2017.
Our Mission
Founded in 2017, Nexopro DMCC focuses on bringing differentiated medical technologies to GCC healthcare markets. We work with manufacturers whose products address meaningful clinical needs and require more than conventional distribution — combining regulatory access, clinical engagement, institutional development, and commercial execution.
2017
Founded
4
Specialized Technologies
6+
Country Markets
GCC
Regional Presence
What Makes Us Different
Specialized Market Focus
We focus on differentiated technologies that require clinical understanding, stakeholder engagement, and structured market development.
Regulatory & Market Access
We navigate registration, institutional access, tender pathways, and local requirements across GCC healthcare markets.
Long-Term Partnerships
We work with manufacturers, clinicians, and healthcare institutions to build sustainable adoption rather than short-term transactional sales.
Our Manufacturing Partners
We work with a select group of innovative medical-device manufacturers whose technologies require specialist clinical and commercial development across the GCC.
Developer of specialized diaphragm pacing technologies including NeuRx DPS® and TransAeris®, as well as Stroke rehab CCFES Synchrony®
Developer of the FlexDex articulated needle driver for MIS
Regulatory Compliance
Nexopro supports market entry and commercialization in accordance with applicable GCC health-authority requirements, including those of EDE/MOHAP in the UAE, SFDA in Saudi Arabia, and relevant health authorities across Kuwait, Qatar, Bahrain, and Oman.